UPCC 12217 Hepatic Adenomas: Building a Biorepository to Examine Genetic and Environmental Contributions to Disease

Enrolling By Invitation
99 years or below
All
Phase N/A
170 participants needed
1 Location

Brief description of study

PRIMARY OBJECTIVE: To conduct a multicenter, observational study of patients with well-characterized hepatic adenoma. At the end of the study, robust clinical information, central bio-repository of genomic DNA and liver tissue (where available) will be developed

SECONDARY OBJECTIVE: To develop the well characterized hepatic adenoma biorepository with linked clinical data that will serve as the foundation for future mechanistic studies. none none

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research
  • Age: 99 years or below
  • Gender: All

TBD

Updated on 22 Apr 2026. Study ID: 17-0106
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Abramson Cancer Center Navigator